Ludger M Dinkelborg Selected Research

Rupture

8/2014	Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
6/2013	Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludger M Dinkelborg Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 10/2005
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2016
2	Thrombosis (Thrombus) 01/2017 - 09/2005
2	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 09/2006
2	Alzheimer Disease (Alzheimer's Disease) 04/2015 - 02/2008
2	Atherosclerotic Plaque (Atheroma) 08/2014 - 06/2013
2	Rupture 08/2014 - 06/2013
2	Neoplasm Metastasis (Metastasis) 06/2013 - 05/2009
2	Inflammation (Inflammations) 09/2011 - 11/2007
2	Atherosclerosis 09/2005 - 03/2002
1	Cognitive Dysfunction 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2013
1	Breast Neoplasms (Breast Cancer) 10/2012
1	Dementia (Dementias) 02/2008
1	Abscess 11/2007
1	Escherichia coli Infections 11/2007
1	Infections 11/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2006
1	Squamous Cell Carcinoma of Head and Neck 07/2006
1	Neointima 02/2006
1	Pathologic Constriction (Stenosis) 02/2006
1	Teratocarcinoma 10/2005
1	Hyperplasia 09/2005

Drug/Important Bio-Agent (IBA)

6	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2011
5	Fibronectins (Fibronectin)IBA 07/2007 - 10/2005
4	Peptides (Polypeptides)IBA 10/2013 - 09/2006
3	Radioisotopes (Radionuclides)IBA 05/2009 - 06/2006
2	Amino Acids FDA Link 01/2016 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2011
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 04/2015 - 02/2008
2	AcidsIBA 06/2013 - 01/2011
2	(4S)-4-(3-(18F)fluoropropyl)-L-glutamateIBA 06/2013 - 09/2011
2	ErbB Receptors (EGF Receptor)IBA 05/2009 - 07/2006
2	Immunoglobulin FragmentsIBA 07/2007 - 10/2006
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 01/2017
1	RadiopharmaceuticalsIBA 01/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	Amyloid (Amyloid Fibrils)IBA 04/2015
1	Matrix Metalloproteinases (MMPs)IBA 08/2014
1	2-fluoro-4-phosphonomethylpentanedioic acidIBA 01/2014
1	AntigensIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	BombesinIBA 10/2013
1	SiliconIBA 10/2013
1	GelatinasesIBA 06/2013
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2012
1	TurpentineIBA 09/2011
1	Glutamine (L-Glutamine)FDA Link 01/2011
1	(99m)Tc-Z(HER2:2395)-CysIBA 05/2009
1	Cysteine (L-Cysteine)FDA Link 05/2009
1	Amyloid beta-PeptidesIBA 02/2008
1	technetium 99m P1827DSIBA 11/2007
1	Interleukin-8 (Interleukin 8)IBA 11/2007
1	technetium Tc 99m interleukin 8IBA 11/2007
1	Technetium (Technetium 99m)IBA 11/2007
1	perrhenate (rhenium oxide)IBA 03/2007
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2007
1	Chelating AgentsIBA 03/2007
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 03/2007
1	Coordination ComplexesIBA 03/2007
1	RheniumIBA 03/2007
1	Extracellular Matrix ProteinsIBA 10/2006
1	HaptensIBA 09/2006
1	Cetuximab (Erbitux)FDA Link 07/2006
1	Contrast MediaIBA 06/2006
1	ElementsIBA 06/2006
1	Sirolimus (Rapamycin)FDA Link 02/2006
1	PolymersIBA 02/2006
1	Immunoconjugates (Immunoconjugate)IBA 10/2005
1	Endothelin Receptors (Endothelin Receptor)IBA 03/2002

Therapy/Procedure

2	Radiotherapy 03/2007 - 09/2006
2	Radioimmunotherapy 07/2006 - 10/2005
2	Therapeutics 06/2006 - 10/2005
2	Stents 02/2006 - 09/2005
1	Catheters 01/2017